Home The Word Brain My Amedeo FAQ Privacy About   


2049 Chinese

The 20K Word Road to Mandarin Proficiency

By B. S. Kamps et al.


  Diseases of the Thyroid

  Free Subscription


Articles published in Endocr J

Retrieve available abstracts of 120 articles:
HTML format



Single Articles


    April 2024
  1. YAMAGAMI A, Iwama S, Kobayashi T, Zhou X, et al
    Changes in TgAb and TPOAb titers are greater in thyrotoxicosis than isolated hypothyroidism induced by PD-1 blockade.
    Endocr J. 2024 Apr 11. doi: 10.1507/endocrj.EJ23-0480.
    PubMed     Abstract available


  2. MURAKAMI T, Higaki N, Nishijima Y, Tani J, et al
    An easy approach to ultrasonographic volumetry of the thyroid.
    Endocr J. 2024 Apr 11. doi: 10.1507/endocrj.EJ23-0606.
    PubMed     Abstract available


    March 2024
  3. SHIBATA N, Numakura C, Hamajima T, Miyako K, et al
    Clinical and molecular analyses of isolated central congenital hypothyroidism based on a survey conducted in Japan.
    Endocr J. 2024 Mar 8. doi: 10.1507/endocrj.EJ23-0391.
    PubMed     Abstract available


    February 2024
  4. NAKAHATA N, Asano M, Abe N, Ejiri H, et al
    Prevalence of thyroid diffuse goiter and its association with body mass index and the presence of cysts and nodules in children and adolescents: the Fukushima Health Management Survey.
    Endocr J. 2024 Feb 16. doi: 10.1507/endocrj.EJ23-0609.
    PubMed     Abstract available


    January 2024
  5. FUKUDA N, Toda K, Suto H, Oki R, et al
    Clinical impact of proteinuria on renal function and treatment outcomes in patients with radioiodine-refractory thyroid cancer treated with lenvatinib.
    Endocr J. 2024 Jan 31. doi: 10.1507/endocrj.EJ23-0378.
    PubMed     Abstract available


  6. DEGUCHI-HORIUCHI H, Ito M, Takahashi S, Kousaka K, et al
    Comparison of pathophysiology in subclinical hyperthyroidism with different etiologies.
    Endocr J. 2024 Jan 31. doi: 10.1507/endocrj.EJ23-0497.
    PubMed     Abstract available


  7. OMI Y, Yanagida J, Yoshida Y, Horiuchi K, et al
    Risk factors for mediastinal lymph node metastasis and lung metastasis in papillary thyroid carcinoma patients: who benefits from preoperative computed tomography?
    Endocr J. 2024 Jan 19. doi: 10.1507/endocrj.EJ23-0413.
    PubMed     Abstract available


    December 2023
  8. TODA S, Iwasaki H, Okubo Y, Hayashi H, et al
    The frequency of mutations in advanced thyroid cancer in Japan: a single-center study.
    Endocr J. 2023 Dec 1. doi: 10.1507/endocrj.EJ23-0342.
    PubMed     Abstract available


    November 2023
  9. KOBAYASHI T, Iwama S, Arima H
    Clinical characteristics and potential biomarkers of thyroid and pituitary immune-related adverse events.
    Endocr J. 2023 Nov 7. doi: 10.1507/endocrj.EJ23-0524.
    PubMed     Abstract available


    October 2023
  10. MO C, Zhong L
    The effect of acromegaly on thyroid disease.
    Endocr J. 2023 Oct 25. doi: 10.1507/endocrj.EJ23-0356.
    PubMed     Abstract available


  11. ITO Y, Miyauchi A, Fujishima M, Yamamoto M, et al
    Active surveillance for adult low-risk papillary thyroid microcarcinoma-a review focused on the 30-year experience of Kuma Hospital.
    Endocr J. 2023 Oct 4. doi: 10.1507/endocrj.EJ23-0395.
    PubMed     Abstract available


    September 2023
  12. HAGA E, Inoue N, Iwatani Y, Arakawa Y, et al
    Intraindividual variation in histone acetylation and its impact on autoimmune thyroid diseases.
    Endocr J. 2023 Sep 30. doi: 10.1507/endocrj.EJ23-0204.
    PubMed     Abstract available


  13. KAWAMOTO T, Yasuda K, Ito Y, Zenda S, et al
    Adjuvant treatments for locally advanced differentiated thyroid cancer: a nationwide survey in Japan.
    Endocr J. 2023 Sep 30. doi: 10.1507/endocrj.EJ23-0330.
    PubMed     Abstract available


  14. WATANABE N, Yoshimura Noh J, Kozaki A, Yoshimura R, et al
    Incidence and risk factors for Graves' orbitopathy in patients who underwent anti-inflammatory and immunosuppressive treatment during medical treatment for Graves' disease: investigation of 1,553 cases with newly diagnosed Graves' disease and proposal
    Endocr J. 2023 Sep 22. doi: 10.1507/endocrj.EJ23-0079.
    PubMed     Abstract available


  15. ARIMITSU H, Nishijima Y, Higaki N, Noguchi H, et al
    A case report of anaplastic thyroid carcinoma transformed from small papillary carcinoma successfully detected by ultrasonography in its early stage with review of literature.
    Endocr J. 2023 Sep 16. doi: 10.1507/endocrj.EJ23-0197.
    PubMed     Abstract available


  16. DEANDREA M, Piticchio T, Mormile A, Retta F, et al
    Preoperative neck ultrasound combined with pathological data can significantly impact the outcome of medullary thyroid carcinoma.
    Endocr J. 2023 Sep 9. doi: 10.1507/endocrj.EJ23-0273.
    PubMed     Abstract available


    August 2023
  17. YAMAUCHI I, Hakata T, Sugawa T, Kosugi D, et al
    Prediction-based prompt levothyroxine replacement to prevent a hypothyroid state after immune-related adverse events involving the thyroid gland.
    Endocr J. 2023 Aug 11. doi: 10.1507/endocrj.EJ23-0262.
    PubMed     Abstract available


  18. MATSUSE M, Mitsutake N
    TERT promoter mutations in thyroid cancer.
    Endocr J. 2023 Aug 1. doi: 10.1507/endocrj.EJ23-0136.
    PubMed     Abstract available


    June 2023
  19. FUJISHIMA M, Miyauchi A, Ito Y, Sasaki T, et al
    Outcomes of immediate surgery for low-risk papillary thyroid microcarcinoma in patients with or without risky features at surgery.
    Endocr J. 2023 Jun 28. doi: 10.1507/endocrj.EJ23-0107.
    PubMed     Abstract available


  20. SHIMMARU K, Inami M, Hamaoka A, Fujiwara N, et al
    Elevated free thyroxine and free triiodothyronine probably caused by high-dose biotin intake in a patient with Graves' disease: a case report.
    Endocr J. 2023 Jun 17. doi: 10.1507/endocrj.EJ23-0062.
    PubMed     Abstract available


    May 2023
  21. TERASHIMA R, Tani T, Sakakibara K, Kurusu S, et al
    Thyrotropin-releasing hormone stimulates NR4A3 expression in the pituitary thyrotrophs of proestrus rats.
    Endocr J. 2023 May 19. doi: 10.1507/endocrj.EJ23-0080.
    PubMed     Abstract available


    April 2023
  22. SHI W, Song D, Chen D, Duan W, et al
    The association of thyroid parameters with markers of chronic kidney disease in euthyroid patients with type 2 diabetes.
    Endocr J. 2023 Apr 21. doi: 10.1507/endocrj.EJ22-0643.
    PubMed     Abstract available


    March 2023
  23. NAGATA K, Hayashi K, Kumata K, Satoh Y, et al
    Epstein-Barr virus reactivation in peripheral B lymphocytes induces IgM-type thyrotropin receptor autoantibody production in patients with Graves' disease.
    Endocr J. 2023 Mar 10. doi: 10.1507/endocrj.EJ22-0609.
    PubMed     Abstract available


    February 2023
  24. MIKURA K, Yoshimura Noh J, Watanabe N, Aida A, et al
    Radioiodine uptake after monotherapy with potassium iodide in patients with Graves' disease.
    Endocr J. 2023 Feb 25. doi: 10.1507/endocrj.EJ22-0505.
    PubMed     Abstract available


  25. ZHANG M, Zhang Y, Qiu Y, Wei H, et al
    A nomogram based on ultrasound characteristics to predict large-number cervical lymph node metastasis in papillary thyroid carcinoma.
    Endocr J. 2023 Feb 4. doi: 10.1507/endocrj.EJ22-0404.
    PubMed     Abstract available


  26. KONISHI A, Koizumi M, Etani Y, Ida S, et al
    Very young children with Prader-Willi syndrome are refractory to growth hormone-associated decreases in free thyroxine levels.
    Endocr J. 2023 Feb 1. doi: 10.1507/endocrj.EJ22-0509.
    PubMed     Abstract available


    January 2023
  27. HORIGUCHI K
    The molecular biology of thyrotroph pituitary neuroendocrine tumors.
    Endocr J. 2023 Jan 19. doi: 10.1507/endocrj.EJ22-0514.
    PubMed     Abstract available


  28. FUJISHIMA M, Miyauchi A, Ito Y, Kudo T, et al
    Active surveillance is an excellent management technique for identifying patients with progressive low-risk papillary thyroid microcarcinoma requiring surgical treatment.
    Endocr J. 2023 Jan 11. doi: 10.1507/endocrj.EJ22-0559.
    PubMed     Abstract available


    December 2022
  29. AKATANI N, Wakabayashi H, Kayano D, Inaki A, et al
    Long-term outcomes and prognostic factors of patients with lung metastases from differentiated thyroid cancer after radioiodine therapy in Japan.
    Endocr J. 2022 Dec 24. doi: 10.1507/endocrj.EJ22-0463.
    PubMed     Abstract available


  30. NARUMI S
    Genome-wide association studies for thyroid physiology and diseases.
    Endocr J. 2022 Dec 7. doi: 10.1507/endocrj.EJ22-0503.
    PubMed     Abstract available


  31. UEBA Y, Yamauchi I, Hakata T, Fujita H, et al
    Delayed-onset immune-related adverse events involving the thyroid gland by immune checkpoint inhibitors in combination with chemotherapy: a case report and retrospective cohort study.
    Endocr J. 2022 Dec 2. doi: 10.1507/endocrj.EJ22-0467.
    PubMed     Abstract available


    November 2022
  32. ITO Y, Miyauchi A, Hirokawa M, Kihara M, et al
    Clinicopathological features and outcomes of intrathyroidal thymic carcinoma: a single institution study.
    Endocr J. 2022;69:1351-1356.
    PubMed     Abstract available


  33. SONG Y, Bai Y, Wang J, Xu G, et al
    Pathologic complete response after neoadjuvant v-Raf murine sarcoma viral oncogene homolog B (BRAF) inhibition combined with immunotherapy therapy for anaplastic thyroid carcinoma: a case report and literature review.
    Endocr J. 2022 Nov 9. doi: 10.1507/endocrj.EJ22-0366.
    PubMed     Abstract available


  34. OKAMURA K, Sato K, Fujikawa M, Bandai S, et al
    Painless thyroiditis mimicking relapse of hyperthyroidism during or after potassium iodide or thionamide therapy for Graves' disease resulting in remission.
    Endocr J. 2022 Nov 9. doi: 10.1507/endocrj.EJ22-0207.
    PubMed     Abstract available


    October 2022
  35. HIRUMA M, Watanabe N, Mitsumatsu T, Suzuki N, et al
    Clinical features of moyamoya disease with Graves' disease: a retrospective study of 394,422 patients with thyroid disease.
    Endocr J. 2022 Oct 5. doi: 10.1507/endocrj.EJ22-0319.
    PubMed     Abstract available


    September 2022
  36. NAGAYAMA Y, Nishihara E
    Thyrotropin receptor antagonists and inverse agonists, and their potential application to thyroid diseases.
    Endocr J. 2022 Sep 27. doi: 10.1507/endocrj.EJ22-0391.
    PubMed     Abstract available


  37. FUJITA N, Ono Y, Kobayashi T, Kozono S, et al
    Iodine-containing ointment-induced hypothyroidism in a patient with anorexia nervosa and sacral decubitus ulcer: a case report with literature review.
    Endocr J. 2022 Sep 3. doi: 10.1507/endocrj.EJ22-0248.
    PubMed     Abstract available


    August 2022
  38. CHAUDHARY S, Dogra V, Walia R
    Four cases of Graves' disease following viral vector severe acute respiratory syndrome corona virus-2 (SARS-CoV-2) vaccine.
    Endocr J. 2022 Aug 18. doi: 10.1507/endocrj.EJ22-0208.
    PubMed     Abstract available


    July 2022
  39. OHBA K, Iwaki T
    Role of thyroid hormone in an experimental model of atherosclerosis: the potential mediating role of immune response and autophagy.
    Endocr J. 2022 Jul 23. doi: 10.1507/endocrj.EJ22-0177.
    PubMed     Abstract available


  40. FUSE Y, Ito Y, Shishiba Y, Irie M, et al
    Gestational trimester-specific reference ranges for serum thyrotropin and free thyroxine in Japanese.
    Endocr J. 2022 Jul 9. doi: 10.1507/endocrj.EJ22-0237.
    PubMed     Abstract available


    June 2022
  41. YAMAMOTO M, Onoda N, Miyauchi A, Fujishima M, et al
    Gauze blotting technique: a novel method to identify parathyroid glands during thyroid surgery without tissue damage.
    Endocr J. 2022 Jun 25. doi: 10.1507/endocrj.EJ22-0043.
    PubMed     Abstract available


  42. HASHIMOTO K
    Update on subclinical thyroid dysfunction.
    Endocr J. 2022 Jun 22. doi: 10.1507/endocrj.EJ22-0182.
    PubMed     Abstract available


  43. WANG HQ, Li Y, Song X, Ma YQ, et al
    Significance of interstitial fibrosis and p16 in papillary thyroid carcinoma.
    Endocr J. 2022 Jun 18. doi: 10.1507/endocrj.EJ22-0010.
    PubMed     Abstract available


  44. NAKAMURA Y, Yoshihara A, Kiriya M, Kawashima A, et al
    Thyroid stimulating hormone suppresses the expression and activity of cytosolic sulfotransferase 1a1 in thyrocytes.
    Endocr J. 2022 Jun 9. doi: 10.1507/endocrj.EJ22-0055.
    PubMed     Abstract available


  45. PARK E, Kim MS, Noh ES, Lee JE, et al
    Multiple endocrine neoplasia type 2 and autoimmune polyendocrine syndromes (type 1 diabetes mellitus and Graves' disease) in a 16-year-old male with Kabuki syndrome.
    Endocr J. 2022 Jun 8. doi: 10.1507/endocrj.EJ22-0084.
    PubMed     Abstract available


  46. MORITANI S, Takenobu M, Yasunaga M, Kawamoto K, et al
    Surgical indications for upper mediastinal dissection by sternotomy in patients with papillary thyroid carcinoma.
    Endocr J. 2022 Jun 2. doi: 10.1507/endocrj.EJ22-0033.
    PubMed     Abstract available


    April 2022
  47. ITO Y, Hirokawa M, Masuoka H, Higashiyama T, et al
    Prognostic factors for follicular thyroid carcinoma: the importance of vascular invasion.
    Endocr J. 2022 Apr 29. doi: 10.1507/endocrj.EJ22-0077.
    PubMed     Abstract available


  48. ITO Y, Miyauchi A, Fujishima M, Masuoka H, et al
    Prognostic significance of patient age in papillary thyroid carcinoma with no high-risk features.
    Endocr J. 2022 Apr 15. doi: 10.1507/endocrj.EJ22-0056.
    PubMed     Abstract available


  49. KANEKO M, Ohara K, Shikata H
    A case of fatal myxedema coma with electrocardiogram Osborne J-wave in a patient initially diagnosed with hypothyroidism.
    Endocr J. 2022 Apr 9. doi: 10.1507/endocrj.EJ21-0720.
    PubMed     Abstract available


  50. YOSHIHARA A, Yoshimura Noh J, Inoue K, Taguchi J, et al
    Prediction model of Graves' disease in general clinical practice based on complete blood count and biochemistry profile.
    Endocr J. 2022 Apr 5. doi: 10.1507/endocrj.EJ21-0741.
    PubMed     Abstract available


    March 2022
  51. OKAMURA K, Sato K, Fujikawa M, Bandai S, et al
    Iodide-sensitive Graves' hyperthyroidism and the strategy for resistant or escaped patients during potassium iodide treatment.
    Endocr J. 2022 Mar 24. doi: 10.1507/endocrj.EJ21-0436.
    PubMed     Abstract available


  52. KISHIMOTO M, Ishikawa T, Odawara M
    Subacute thyroiditis with liver dysfunction following coronavirus disease 2019 (COVID-19) vaccination: report of two cases and a literature review.
    Endocr J. 2022 Mar 10. doi: 10.1507/endocrj.EJ21-0629.
    PubMed     Abstract available


  53. JOJIMA T, Shinzawa T, Ohira E, Sakurai S, et al
    Switching from the tablet to the powder formulation of levothyroxine corrects severe hypothyroidism in a patient with lactose intolerance.
    Endocr J. 2022 Mar 4. doi: 10.1507/endocrj.EJ21-0656.
    PubMed     Abstract available


    February 2022
  54. KAZAKOVA D, Shimamura M, Kurashige T, Hamada K, et al
    Re-evaluation of the role of autophagy in thyroid cancer treatment.
    Endocr J. 2022 Feb 22. doi: 10.1507/endocrj.EJ22-0017.
    PubMed     Abstract available


  55. GAO J, Hu J, Li P, Che K, et al
    Human umbilical cord mesenchymal stem cells alleviate the imbalance of CD4(+) T cells via protein tyrosine phosphatase non-receptor type 2/signal transducer and activator of transcription 3 signaling in ameliorating experimental autoimmune thyroiditis
    Endocr J. 2022 Feb 10. doi: 10.1507/endocrj.EJ20-0695.
    PubMed     Abstract available


  56. MARZOUKI H, Alrowaizen S, Ageel M, Nujoom M, et al
    The long-term impact of neck scar satisfaction among thyroid surgery patients.
    Endocr J. 2022 Feb 5. doi: 10.1507/endocrj.EJ21-0577.
    PubMed     Abstract available


    January 2022
  57. ITO Y, Hirokawa M, Hayashi T, Kihara M, et al
    Clinical outcomes of follicular tumor of uncertain malignant potential of the thyroid: real-world data.
    Endocr J. 2022 Jan 26. doi: 10.1507/endocrj.EJ21-0723.
    PubMed     Abstract available


  58. SUN D, Zhou L, Wang S, Liu T, et al
    Effect of Di-(2-ethylhexyl) phthalate on the hypothalamus-pituitary-thyroid axis in adolescent rat.
    Endocr J. 2022;69:217-224.
    PubMed     Abstract available


    December 2021
  59. NODA T, Miyauchi A, Ito Y, Kudo T, et al
    Observational management of papillary microcarcinoma appearing in the remnant thyroid after hemithyroidectomy.
    Endocr J. 2021 Dec 25. doi: 10.1507/endocrj.EJ21-0557.
    PubMed     Abstract available


  60. NAKAMURA S, Kido N, Watanabe M, Ohmachi Y, et al
    Analysis of thyroid function in Japanese patients with coronavirus disease 2019.
    Endocr J. 2021 Dec 24. doi: 10.1507/endocrj.EJ21-0609.
    PubMed     Abstract available


    November 2021
  61. SUNADA N, Hanayama Y, Yamamoto K, Nakano Y, et al
    Clinical utility of urinary levels of catecholamines and their fraction ratios related to heart rate and thyroid function.
    Endocr J. 2021 Nov 3. doi: 10.1507/endocrj.EJ21-0488.
    PubMed     Abstract available


  62. KURE S, Chiba T, Ebina A, Toda K, et al
    Correlation between low expression of protein disulfide isomerase A3 and lymph node metastasis in papillary thyroid carcinoma and poor prognosis: a clinicopathological study of 1,139 cases with long-term follow-up.
    Endocr J. 2021 Nov 2. doi: 10.1507/endocrj.EJ21-0394.
    PubMed     Abstract available


    October 2021
  63. FUKUSHITA M, Watanabe N, Yoshimura Noh J, Yoshihara A, et al
    A case of macro-TSH consisting of IgA-bound TSH.
    Endocr J. 2021;68:1241-1246.
    PubMed     Abstract available


  64. SUZUKI A, Hirokawa M, Kanematsu R, Tanaka A, et al
    B-cell to T-cell ratio as a novel indicator in flow cytometry in the diagnosis of thyroid lymphoma.
    Endocr J. 2021 Oct 21. doi: 10.1507/endocrj.EJ21-0451.
    PubMed     Abstract available


  65. YAMAGUCHI Y, Uchimura K, Takahashi K, Ishii T, et al
    Hyperthyroidism exacerbates ischemic reperfusion injury in the kidney.
    Endocr J. 2021 Oct 9. doi: 10.1507/endocrj.EJ21-0395.
    PubMed     Abstract available


  66. FUKATA S, Ito M, Nishikawa M, Kasahara T, et al
    Hypothyroidism due to nephrotic syndrome: a notable clinical entity.
    Endocr J. 2021 Oct 6. doi: 10.1507/endocrj.EJ21-0387.
    PubMed     Abstract available


    September 2021
  67. CAO X, Zhu J, Li X, Ma Y, et al
    Expression of CXCR4 and CXCR7 in papillary thyroid carcinoma and adjacent tissues and their relationship with pathologic indicators of tumor aggressiveness.
    Endocr J. 2021 Sep 28. doi: 10.1507/endocrj.EJ21-0076.
    PubMed     Abstract available


  68. ZHENG H, Fu Q, Ma K, Shi S, et al
    Circ_0079558 promotes papillary thyroid cancer progression by binding to miR-26b-5p to activate MET/AKT signaling.
    Endocr J. 2021 Sep 25. doi: 10.1507/endocrj.EJ20-0498.
    PubMed     Abstract available


  69. OHBA K, Sasaki S, Misawa Nakamura H, Matsushita A, et al
    Clinical outcomes of 34 patients with resistance to thyroid hormone beta: a twenty-year experience in Japan.
    Endocr J. 2021 Sep 22. doi: 10.1507/endocrj.EJ21-0390.
    PubMed     Abstract available


  70. OKAMURA K, Ibayashi H, Sato K, Fujikawa M, et al
    A case of Graves' disease presenting with internal ophthalmoplegia during methylmercaptoimidazole treatment.
    Endocr J. 2021 Sep 18. doi: 10.1507/endocrj.EJ21-0340.
    PubMed     Abstract available


  71. KAMMA H, Kameyama K, Kondo T, Imamura Y, et al
    Pathological diagnosis of general rules for the description of thyroid cancer by Japanese Society of Thyroid Pathology and Japan Association of Endocrine Surgery.
    Endocr J. 2021 Sep 15. doi: 10.1507/endocrj.EJ21-0388.
    PubMed     Abstract available


  72. MINAKATA M, Ito M, Kishi T, Hada M, et al
    The magnitude of increased Levothyroxine dose during pregnancy in patients on thyroid-stimulating hormone (TSH) suppression treatment after total thyroidectomy for papillary carcinoma.
    Endocr J. 2021 Sep 14. doi: 10.1507/endocrj.EJ21-0109.
    PubMed     Abstract available


  73. LIU H, Yao XY, Zheng ZQ, Chen SJ, et al
    Analysis of risk factors for posterior laryngeal recurrent nerve metastasis in micropapillary thyroid carcinoma.
    Endocr J. 2021 Sep 7. doi: 10.1507/endocrj.EJ21-0073.
    PubMed     Abstract available


    August 2021
  74. FUKUSHIMA M, Fukunari N, Murakami T, Kunii Y, et al
    Reconfirmation of the accuracy of the taller-than-wide sign in multicenter collaborative research in Japan.
    Endocr J. 2021;68:897-904.
    PubMed     Abstract available


  75. YOKOMICHI H, Mochizuki M, Kojima R, Horiuchi S, et al
    Mother's iodine exposure and infants' hypothyroidism: the Japan environment and children's study.
    Endocr J. 2021 Aug 26. doi: 10.1507/endocrj.EJ21-0168.
    PubMed     Abstract available


  76. TOI N, Kurajoh M, Miyaoka D, Nagata Y, et al
    Bexarotene-induced central hypothyroidism assessed by TRH stimulation test in cutaneous T-cell lymphoma patients.
    Endocr J. 2021 Aug 25. doi: 10.1507/endocrj.EJ21-0313.
    PubMed     Abstract available


  77. KIM J, Shin JH, Oh YL, Hahn SY, et al
    Approach to Bethesda system category III thyroid nodules according to US-risk stratification.
    Endocr J. 2021 Aug 18. doi: 10.1507/endocrj.EJ21-0300.
    PubMed     Abstract available


    July 2021
  78. WATANABE N, Yoshimura Noh J, Akamizu T, Yamada M, et al
    Survey of the actual administration of thiamazole for hyperthyroidism in Japan by the Japan Thyroid Association.
    Endocr J. 2021 Jul 29. doi: 10.1507/endocrj.EJ21-0238.
    PubMed     Abstract available


  79. KIHARA M, Miyauchi A, Hirokawa M, Masuoka H, et al
    Long-term outcomes of cytologically benign thyroid tumors: a retrospective analysis of 3,102 patients at a single institution.
    Endocr J. 2021 Jul 16. doi: 10.1507/endocrj.EJ21-0252.
    PubMed     Abstract available


  80. WATANABE D, Yagasaki H, Narusawa H, Saito T, et al
    Screening of frequent variants associated with congenital hypothyroidism: a comparison with next generation sequencing.
    Endocr J. 2021 Jul 8. doi: 10.1507/endocrj.EJ21-0353.
    PubMed     Abstract available


  81. ITO Y, Hirokawa M, Kousaka K, Ito M, et al
    Diagnosis and management of hyalinizing trabecular tumor of the thyroid: a single-institution experience.
    Endocr J. 2021 Jul 6. doi: 10.1507/endocrj.EJ21-0143.
    PubMed     Abstract available


  82. OBA T, Maeno K, Amitani M, Shimizu T, et al
    Prognostic significance of neutrophil-to-lymphocyte ratio for long-term outcomes in patients with poorly differentiated thyroid cancer.
    Endocr J. 2021 Jul 2. doi: 10.1507/endocrj.EJ21-0237.
    PubMed     Abstract available


    June 2021
  83. FUJISHIMA M, Miyauchi A, Ito Y, Kudo T, et al
    Evaluation of the diagnostic utility of the aminotransferase/lactate dehydrogenase ratio for the suspension of tissue specimens during thyroid surgery for the identification of parathyroid tissue.
    Endocr J. 2021 Jun 15. doi: 10.1507/endocrj.EJ21-0128.
    PubMed     Abstract available


  84. HAYASHI T, Akiyama N, Kanematsu R, Higuchi M, et al
    Potential role of mobile rapid on-site evaluation((R)) in thyroid fine-needle aspiration cytology to reduce delayed repeated aspiration.
    Endocr J. 2021 Jun 12. doi: 10.1507/endocrj.EJ21-0010.
    PubMed     Abstract available


  85. MAO Y, Huo Y, Li J, Zhao Y, et al
    circRPS28 (hsa_circ_0049055) is a novel contributor for papillary thyroid carcinoma by regulating cell growth and motility via functioning as ceRNA for miR-345-5p to regulate frizzled family receptor 8 (FZD8).
    Endocr J. 2021 Jun 10. doi: 10.1507/endocrj.EJ21-0072.
    PubMed     Abstract available


  86. HANAI S, Uchimura K, Takahashi K, Ishii T, et al
    Hypoxia-induced thyroid hormone receptor expression regulates cell-cycle progression in renal tubule epithelial cells.
    Endocr J. 2021 Jun 8. doi: 10.1507/endocrj.EJ21-0245.
    PubMed     Abstract available


  87. LI X, Yang S, Zhao C, Yang J, et al
    CircHACE1 functions as a competitive endogenous RNA to curb differentiated thyroid cancer progression by upregulating Tfcp2L1 through adsorbing miR-346.
    Endocr J. 2021 Jun 4. doi: 10.1507/endocrj.EJ20-0806.
    PubMed     Abstract available


    May 2021
  88. OKADA J, Isoda A, Hoshi H, Watanabe T, et al
    Free triiodothyronine /free thyroxine ratio as an index of deiodinase type 1 and 2 activities negatively correlates with casual serum insulin levels in patients with type 2 diabetes mellitus.
    Endocr J. 2021 May 11. doi: 10.1507/endocrj.EJ21-0169.
    PubMed     Abstract available


  89. KAKUDO K, Liu Z, Bai Y, Li Y, et al
    How to identify indolent thyroid tumors unlikely to recur and cause cancer death immediately after surgery-Risk stratification of papillary thyroid carcinoma in young patients.
    Endocr J. 2021 May 11. doi: 10.1507/endocrj.EJ21-0018.
    PubMed     Abstract available


  90. MIZOKAMI T, Hamada K, Maruta T, Higashi K, et al
    Utility of outpatient fractionated radioiodine therapy for Graves disease involving a large goiter measuring more than 100 mL in volume.
    Endocr J. 2021 May 11. doi: 10.1507/endocrj.EJ20-0836.
    PubMed     Abstract available


  91. IIJIMA T, Jojima T, Hosonuma S, Ohhira E, et al
    Symptomatic hypocalcemia after treatment for hyperthyroidism in a woman with chromosome 22q11.2 deletion syndrome complicated by Graves' disease: longitudinal changes in the number of subsets of CD4 and CD8 lymphocytes after thyroidectomy.
    Endocr J. 2021 May 11. doi: 10.1507/endocrj.EJ20-0717.
    PubMed     Abstract available


    April 2021
  92. DING X, Zhao Y, Zhu CY, Wu LP, et al
    The association between subclinical hypothyroidism and metabolic syndrome: an update meta-analysis of observational studies.
    Endocr J. 2021 Apr 21. doi: 10.1507/endocrj.EJ20-0796.
    PubMed     Abstract available


  93. SAKAMOTO A, Hirokawa M, Ito M, Naganuma H, et al
    Introduction of histological classification and cytology reporting format of the Japanese General Rules for the Description of Thyroid Cancer with a special focus on the differences of the WHO Histological Classification and The Bethesda System of Thy
    Endocr J. 2021 Apr 13. doi: 10.1507/endocrj.EJ21-0077.
    PubMed     Abstract available


  94. TAGAMI T
    An overview of thyroid function tests in subjects with resistance to thyroid hormone and related disorders.
    Endocr J. 2021 Apr 6. doi: 10.1507/endocrj.EJ21-0059.
    PubMed     Abstract available


    March 2021
  95. LI H, Yang M, Shen H, Wang S, et al
    Severe metabolic disorders coexisting with Werner syndrome: a case report.
    Endocr J. 2021;68:261-267.
    PubMed     Abstract available


  96. HORIGUCHI K, Yoshida Y, Iwaku K, Emoto N, et al
    Position paper from the Japan Thyroid Association task force on the management of low-risk papillary thyroid microcarcinoma (T1aN0M0) in adults.
    Endocr J. 2021 Mar 23. doi: 10.1507/endocrj.EJ20-0692.
    PubMed     Abstract available


  97. ITO Y, Hirokawa M, Fujishima M, Masuoka H, et al
    Prognostic significance of vascular invasion and cell-proliferation activity in widely invasive follicular carcinoma of the thyroid.
    Endocr J. 2021 Mar 20. doi: 10.1507/endocrj.EJ21-0064.
    PubMed     Abstract available


  98. LIU Y, Chen G, Wang B, Wu H, et al
    Silencing circRNA protein kinase C iota (circ-PRKCI) suppresses cell progression and glycolysis of human papillary thyroid cancer through circ-PRKCI/miR-335/E2F3 ceRNA axis.
    Endocr J. 2021 Mar 13. doi: 10.1507/endocrj.EJ20-0726.
    PubMed     Abstract available


  99. SHIMATSU A, Nakamura A, Takahashi Y, Fujio S, et al
    Preoperative and long-term efficacy and safety of lanreotide autogel in patients with thyrotropin-secreting pituitary adenoma: a multicenter, single-arm, phase 3 study in Japan.
    Endocr J. 2021 Mar 11. doi: 10.1507/endocrj.EJ20-0707.
    PubMed     Abstract available


    February 2021
  100. HIRUMA M, Sasano Y, Watanabe N, Yoshihara A, et al
    Propylthiouracil-induced otitis media with anti-neutrophil cytoplasmic antibody-associated vasculitis: a case report and review of the literature.
    Endocr J. 2021;68:145-151.
    PubMed     Abstract available


  101. WANG D, Zheng Y
    Silencing long non-coding RNAs nicotinamide nucleotide transhydrogenase antisense RNA 1 inhibited papillary thyroid cancer cell proliferation, migration and invasion and promoted apoptosis via targeting miR-199a-5p.
    Endocr J. 2021 Feb 20. doi: 10.1507/endocrj.EJ20-0353.
    PubMed     Abstract available


  102. TANIMURA Y, Kiriya M, Kawashima A, Mori H, et al
    Regulation of solute carrier family 26 member 7 (Slc26a7) by thyroid stimulating hormone in thyrocytes.
    Endocr J. 2021 Feb 14. doi: 10.1507/endocrj.EJ20-0502.
    PubMed     Abstract available


  103. NISHIHARA E, Ito Y, Kudo T, Ito M, et al
    Favorable outcomes of papillary thyroid microcarcinoma concurrent with Graves' disease after radioactive iodine therapy.
    Endocr J. 2021 Feb 6. doi: 10.1507/endocrj.EJ20-0753.
    PubMed     Abstract available


    January 2021
  104. FUKUDA N, Toda K, Wang X, Ohmoto A, et al
    Prognostic significance of 8 weeks' relative dose intensity of lenvatinib in treatment of radioiodine-refractory differentiated thyroid cancer patients.
    Endocr J. 2021 Jan 28. doi: 10.1507/endocrj.EJ20-0754.
    PubMed     Abstract available


  105. YAMADA Y, Orita M, Matsunaga H, Yamaguchi T, et al
    Risk perception regarding implementation of iodine thyroid blocking during a nuclear disaster of mothers living near a nuclear power station in Japan.
    Endocr J. 2021 Jan 21. doi: 10.1507/endocrj.EJ20-0627.
    PubMed     Abstract available


  106. DAMIAO CP, Montero JRG, Moran MBH, de Oliveira Marcal E Silva Carvalho ME, et al
    Application of thermography in the diagnostic investigation of thyroid nodules.
    Endocr J. 2021 Jan 21. doi: 10.1507/endocrj.EJ20-0541.
    PubMed     Abstract available


  107. MA J, Kan Z
    Circular RNA circ_0008274 enhances the malignant progression of papillary thyroid carcinoma via modulating solute carrier family 7 member 11 by sponging miR-154-3p.
    Endocr J. 2021 Jan 19. doi: 10.1507/endocrj.EJ20-0453.
    PubMed     Abstract available


  108. SPEER G, Somogyi P
    Thyroid complications of SARS and coronavirus disease 2019 (COVID-19).
    Endocr J. 2021 Jan 19. doi: 10.1507/endocrj.EJ20-0443.
    PubMed     Abstract available


  109. WATANABE T, Temma Y, Okada J, Yamada E, et al
    In patients with type 2 diabetes the presence of Hashimoto's thyroiditis reduces the beneficial effect of dipeptidyl peptidase-4 inhibitor on plasma glucose control.
    Endocr J. 2021 Jan 7. doi: 10.1507/endocrj.EJ20-0620.
    PubMed     Abstract available


    December 2020
  110. TAKESHIMA K, Li Y, Kakudo K, Hirokawa M, et al
    Proposal of diagnostic criteria for IgG4-related thyroid disease.
    Endocr J. 2020 Dec 12. doi: 10.1507/endocrj.EJ20-0557.
    PubMed     Abstract available


    November 2020
  111. TAKAHASHI S, Ito M, Masaki Y, Hada M, et al
    Association between serum thyroid hormone balance and thyroid volume in patients treated with levothyroxine monotherapy for hypothyroidism.
    Endocr J. 2020 Nov 25. doi: 10.1507/endocrj.EJ20-0542.
    PubMed     Abstract available


  112. MIZUNO S, Inaba H, Kobayashi KI, Kubo K, et al
    A case of postpartum thyroiditis following SARS-CoV-2 infection.
    Endocr J. 2020 Nov 12. doi: 10.1507/endocrj.EJ20-0553.
    PubMed     Abstract available


    October 2020
  113. YUAN X, Wang J, Gao Y, Wang H, et al
    Impact of maternal thyroid hormone in late pregnancy on adverse birth outcomes: A retrospective cohort study in China.
    Endocr J. 2020 Oct 27. doi: 10.1507/endocrj.EJ20-0377.
    PubMed     Abstract available


  114. LI S, Li W, Sheng B, Zhu X, et al
    Relationship between thyroid disorders and uterine fibroids among reproductive-age women.
    Endocr J. 2020 Oct 8. doi: 10.1507/endocrj.EJ20-0340.
    PubMed     Abstract available


  115. INABA H, Ariyasu H, Iwakura H, Kurimoto C, et al
    Distinct clinical features and prognosis between persistent and temporary thyroid dysfunctions by immune-checkpoint inhibitors.
    Endocr J. 2020 Oct 3. doi: 10.1507/endocrj.EJ20-0371.
    PubMed     Abstract available


  116. TSUNEMI A, Uchida T, Kuroda K, Ikemoto Y, et al
    Effect of thyroxine treatment on pregnancy outcomes in infertile Japanese women with TSH levels between 2.5 muIU/mL and the upper reference limit: a retrospective study.
    Endocr J. 2020 Oct 1. doi: 10.1507/endocrj.EJ20-0380.
    PubMed     Abstract available


    April 2020
  117. KO J, Kim JY, Kim JW, Yoon JS, et al
    Anti-oxidative and anti-adipogenic effects of caffeine in an in vitro model of Graves' orbitopathy.
    Endocr J. 2020;67:439-447.
    PubMed     Abstract available


    February 2020
  118. ZHU XH, Zhou JN, Qian YY, Yang K, et al
    Diagnostic values of thyroglobulin in lymph node fine-needle aspiration washout: a systematic review and meta-analysis diagnostic values of FNA-Tg.
    Endocr J. 2020;67:113-123.
    PubMed     Abstract available


  119. SHIMAZAKI S, Kazukawa I, Mori K, Kihara M, et al
    Factors predicting endocrine late effects in childhood cancer survivors from a Japanese hospital.
    Endocr J. 2020;67:131-140.
    PubMed     Abstract available


    January 2020
  120. UCHIDA T, Yamaguchi H, Kushima C, Yonekawa T, et al
    Elevated levels of circulating fibroblast growth factor 23 with hypercalcemia following discontinuation of denosumab.
    Endocr J. 2020;67:31-35.
    PubMed     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Diseases of the Thyroid is free of charge.